NHS National Framework Agreement for the supply of Recombinant Factor IX products for the treatment of bleeding disorders
Estimated value
£50.6m
Awarded value
£41.0m
Awarded 02 Jun 2016
Suppliers
1
Lots
1
1 awarded
Published
17 Aug 2018
Deadline 23 Mar 2016
Awarded suppliers· 1 supplier
Awarded 02 Jun 2016 · Contract period 31 Aug 2016 — 28 Feb 2019
Award value
£41.0m